STOCK TITAN
  1. Home
  2. Financials
  3. TNXP
  4. Revenue

Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue by Year

TNXP

Tonix Pharmaceuticals Holding Corp. generated $13.1M in revenue in fiscal year 2025. This represents an increase of 29.8% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $29.1M in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Tonix Pharmaceuticals Holding Corp. has filed alongside them.

FY2025 annual
Revenue $13.1M
YoY +29.8%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TNXP Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Revenue$29.1M$13.1M+29.8%$10.1M+29.9%$7.8MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

TNXP Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$13.5M+577.9%$6.9M+183.2%$5.4M+108.8%$3.3M+16.6%$2.0M-9.5%$2.4M-2.1%$2.6M$2.8M-29.3%$2.2M$2.5MN/A$4.0M

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Tonix Pharmaceuticals Holding Corp. financials

Frequently Asked Questions

What was Tonix Pharmaceuticals Holding Corp.'s revenue in fiscal year 2025?

Tonix Pharmaceuticals Holding Corp. generated $13.1M in revenue in fiscal year 2025.

How fast is Tonix Pharmaceuticals Holding Corp.'s revenue growing?

Tonix Pharmaceuticals Holding Corp. (TNXP) revenue rose by 29.8% year over year, from $10.1M to $13.1M in fiscal year 2025.

What is Tonix Pharmaceuticals Holding Corp.'s revenue over the last twelve months?

Tonix Pharmaceuticals Holding Corp. (TNXP) reported $29.1M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Tonix Pharmaceuticals Holding Corp. (TNXP) reported $13.5M in revenue in Q2 2026. This represents an increase of 577.9% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Tonix Pharmaceuticals Holding Corp. (TNXP) reported on that line in every period on record.